How to Use Dankare Plus Scalp Solution

Treatments for scalp psoriasis with emphasis on calcipotriol plus betamethasone dipropionate gel (Xamiol)

Affiliations

• PMID: 19585059

Free article

Treatments for scalp psoriasis with emphasis on calcipotriol plus betamethasone dipropionate gel (Xamiol)

L C Guenther . Skin Therapy Lett. 2009 May .

Free article

Abstract

Scalp psoriasis occurs in 50%-75% of patients with plaque psoriasis. It may be the only area of the body affected, or it may be associated with disease elsewhere, including psoriatic arthritis. Most cases are treated topically, usually with steroids and/or calcipotriol. In 2008, Health Canada and the US FDA approved a stable, once-daily 2-compound gel containing calcipotriol and betamethasone dipropionate (Xamiol, LEO Pharma; Taclonex Scalp, Warner Chilcott). This once-daily therapy improves patient quality of life with a quick onset of action and greater efficacy than monotherapy with either ingredient or twice daily treatment with calcipotriol 0.005% (Dovonex, LEO Pharma) scalp solution. The gel vehicle was developed for ease of use, improved cosmetic acceptability and absorption on the scalp. By 2 weeks, approximately 60%, and by 8 weeks, approximately 70% of patients have controlled disease (i.e., absent or very mild disease). At 8 weeks, the calcipotriol and betamethasone dipropionate gel formulation has a safety profile comparable with betamethasone dipropionate and is associated with significantly fewer adverse events than calcipotriol. Xamiol may be safely used for up to 52 weeks. No cases of atrophy, striae, or steroid purpura were noted in two 52-week studies.

Similar articles

• Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial.

  Kragballe K, Hoffmann V, Ortonne JP, Tan J, Nordin P, Segaert S. Kragballe K, et al. Br J Dermatol. 2009 Jul;161(1):159-66. doi: 10.1111/j.1365-2133.2009.09116.x. Epub 2009 Mar 26. Br J Dermatol. 2009. PMID: 19416259 Clinical Trial.

• A new scalp formulation of calcipotriol plus betamethasone dipropionate compared with each of its active ingredients in the same vehicle for the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.

  van de Kerkhof PC, Hoffmann V, Anstey A, Barnes L, Bolduc C, Reich K, Saari S, Segaert S, Vaillant L. van de Kerkhof PC, et al. Br J Dermatol. 2009 Jan;160(1):170-6. doi: 10.1111/j.1365-2133.2008.08927.x. Epub 2008 Nov 25. Br J Dermatol. 2009. PMID: 19067709 Clinical Trial.

• Quality of life in patients with scalp psoriasis treated with calcipotriol/betamethasone dipropionate scalp formulation: a randomized controlled trial.

  Ortonne JP, Ganslandt C, Tan J, Nordin P, Kragballe K, Segaert S. Ortonne JP, et al. J Eur Acad Dermatol Venereol. 2009 Aug;23(8):919-26. doi: 10.1111/j.1468-3083.2009.03221.x. Epub 2009 May 18. J Eur Acad Dermatol Venereol. 2009. PMID: 19453810 Clinical Trial.

• Calcipotriol/betamethasone dipropionate: a review of its use in the treatment of psoriasis vulgaris of the trunk, limbs and scalp.

  McCormack PL. McCormack PL. Drugs. 2011 Apr 16;71(6):709-30. doi: 10.2165/11207300-000000000-00000. Drugs. 2011. PMID: 21504248 Review.

Cited by 2 articles

• Calcipotriol/betamethasone for the treatment of psoriasis: efficacy, safety, and patient acceptability.

  Rogalski C. Rogalski C. Psoriasis (Auckl). 2015 Jun 8;5:97-107. doi: 10.2147/PTT.S63127. eCollection 2015. Psoriasis (Auckl). 2015. PMID: 29387586 Free PMC article. Review.

• Safety and efficacy of calcipotriene plus betamethasone dipropionate topical suspension in the treatment of extensive scalp psoriasis in adolescents ages 12 to 17 years.

  Eichenfield LF, Ganslandt C, Kurvits M, Schlessinger J. Eichenfield LF, et al. Pediatr Dermatol. 2015 Jan-Feb;32(1):28-35. doi: 10.1111/pde.12429. Epub 2014 Nov 21. Pediatr Dermatol. 2015. PMID: 25412565 Free PMC article. Clinical Trial.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Skin Therapy Letter

• Medical

  • Genetic Alliance
  • MedlinePlus Health Information

How to Use Dankare Plus Scalp Solution

Source: https://pubmed.ncbi.nlm.nih.gov/19585059/

Share this post